Accueil>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>Sucralose

Sucralose

Catalog No.GC10278

Le sucralose(E955; trichlorosaccharose) est un édulcorant artificiel non nutritif et un substitut du sucre. Le sucralose peut activer une réponse de jeÛne neuronal conservée et exerce ainsi un effet stimulant l'appétit chez les rongeurs.

Products are for research use only. Not for human use. We do not sell to patients.

Sucralose Chemical Structure

Cas No.: 56038-13-2

Taille Prix Stock Qté
10mM (in 1mL DMSO)
44,00 $US
En stock
50mg
46,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Sucralose is an intense organochlorine artificial sweetener.

The results show that Sucralose induces significant increased incidence of all hematopoietic neoplasias in male mice exposed to 2,000 (p≤0.01), and 16,000 ppm (p≤0.01), with a significant dose-related relationship (p≤0.01). Microscopically, most of the neoplasias among male mice treated with Sucralose at 2,000 to 16,000 ppm are leukemias involving lungs, liver, spleen, lymph nodes, and bone marrow with diffuse permeation of vessels and extensive infiltration of adjacent tissues[1].

References:
[1]. M S, et al. Sucralose administered in feed, beginning prenatally through lifespan, induces hematopoietic neoplasias in male swiss mice. Int J Occup Environ Health. 2016 Jan;22(1):7-17.

Avis

Review for Sucralose

Average Rating: 5 ★★★★★ (Based on Reviews and 31 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sucralose

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.